Access cutting-edge stroke treatment through this clinical trial at a research site in Atlantis. Study-provided care at no cost to qualified participants.
Access stroke specialists in Atlantis at no cost
This study follows strict safety protocols and ethical guidelines
All study-related stroke treatment provided free
This is a Phase 2/3 study evaluating the safety and efficacy of DM199 (rinvecalinase alfa) in treating participants with moderate stroke severity, who present within 24 hours of Acute Ischemic Stroke (AIS) onset due to small and medium vessel occlusions. This study focuses on participants with limited treatment options. Participants who have or will receive mechanical thrombectomy (MT) are not eligible for participation. Additionally, participants who have received fibrinolytics are excluded unl
Sponsor: DiaMedica Therapeutics Inc
Check if you qualify for this stroke clinical trial in Atlantis, FL
If you're searching for stroke treatment options in Atlantis, FL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Atlantis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced stroke specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.